Pre-Open Stock Movers 01/03: (WLL) (ACOR) (TSLA) Higher; (NOVN) (LNDC) (INCY) Lower (more...)

Go back to Pre-Open Stock Movers 01/03: (WLL) (ACOR) (TSLA) Higher; (NOVN) (LNDC) (INCY) Lower (more...)

Incyte (INCY) Reports EMA Validation of Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma

January 7, 2020 6:03 AM EST

Incyte (NASDAQ: INCY) today announced the validation of the Companys Marketing Authorization Application (MAA) for pemigatinib for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that is relapsed or refractory after at least one line of systemic therapy. The European Medicines Agencys (EMA) validation of the MAA confirms that the submission is sufficiently complete to begin the formal review process.

The EMAs validation of Incytes Marketing Authorization Application opens the review process as we seek to bring the... More

Tesla (TSLA) Extends Gain, up 3%

January 3, 2020 9:33 AM EST

Tesla (NASDAQ: TSLA) Extends Gain, up 3%

... More